Health IT Analytics October 15, 2020
Researchers will use artificial intelligence to discover new biomarkers and drug targets for Alzheimer’s disease.
A team at the Perelman School of Medicine at the University of Pennsylvania will leverage artificial intelligence to find patterns in genetic, imaging, and clinical data from over 60,000 Alzheimer’s patients, with the goal of identifying new biomarkers of the disease.
With a $17.8 million grant from the National Institute on Aging at NIH, Penn Medicine investigators will partner with 11 research centers to determine more precise diagnostic biomarkers and drug targets for Alzheimer’s disease, which impacts nearly 50 million people globally.
Researchers and developers are still searching for effective Alzheimer’s disease drugs, but experts believe that identifying biomarkers – early biological signs of the...
Today's Sponsors
Today's Sponsor